Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Laakso

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
Volcanic controls on seawater sulfate over the past 120 million yearsThomas A Laakso, Anna Waldeck, Francis A Macdonald, et al.
Physics in Medicine and Biology|October 8, 2016
How to include the variability of TMS responses in simulations: a speech mapping case studyN De Geeter, P Lioumis, A Laakso, et al.
Psychopharmacology|August 1, 1994
Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatmentsE P Pälvimäki, A Laakso, M Kuoppamäki, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1996
Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexusA Laakso, E P Pälvimäki, M Kuoppamäki, et al.
Geobiology|April 30, 2015
Modeling the carbon cycle in Lake MatanoL B Kuntz, T A Laakso, D P Schrag, et al.
Synapse (New York, N.Y.)|March 6, 1998
[18F]CFT [(18F)WIN 35,428], a radioligand to study the dopamine transporter with PET: characterization in human subjectsA Laakso, J Bergman, M Haaparanta, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Ediacaran reorganization of the marine phosphorus cycleThomas A Laakso, Erik A Sperling, David T Johnston, et al.
Psychopharmacology|October 12, 2001
Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatmentJ Hietala, M Kuonnamäki, E P Pälvimäki, et al.
Pharmacopsychiatry|February 3, 2006
Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brainE Syvälahti, J Penttilä, H Majasuo, et al.
The Journal of Antibiotics|February 7, 2004
R176502, a new bafilolide metabolite with potent antiproliferative activity from a novel Micromonospora speciesJodi A Laakso, Ursula M Mocek, Jacky Van Dun, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
Volcanic controls on seawater sulfate over the past 120 million yearsThomas A Laakso, Anna Waldeck, Francis A Macdonald, et al.
Physics in Medicine and Biology|October 8, 2016
How to include the variability of TMS responses in simulations: a speech mapping case studyN De Geeter, P Lioumis, A Laakso, et al.
Psychopharmacology|August 1, 1994
Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatmentsE P Pälvimäki, A Laakso, M Kuoppamäki, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1996
Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexusA Laakso, E P Pälvimäki, M Kuoppamäki, et al.
Geobiology|April 30, 2015
Modeling the carbon cycle in Lake MatanoL B Kuntz, T A Laakso, D P Schrag, et al.
Synapse (New York, N.Y.)|March 6, 1998
[18F]CFT [(18F)WIN 35,428], a radioligand to study the dopamine transporter with PET: characterization in human subjectsA Laakso, J Bergman, M Haaparanta, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Ediacaran reorganization of the marine phosphorus cycleThomas A Laakso, Erik A Sperling, David T Johnston, et al.
Psychopharmacology|October 12, 2001
Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatmentJ Hietala, M Kuonnamäki, E P Pälvimäki, et al.
Pharmacopsychiatry|February 3, 2006
Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brainE Syvälahti, J Penttilä, H Majasuo, et al.
The Journal of Antibiotics|February 7, 2004
R176502, a new bafilolide metabolite with potent antiproliferative activity from a novel Micromonospora speciesJodi A Laakso, Ursula M Mocek, Jacky Van Dun, et al.
Pageof 5